Compounding pharmacies are typically allowed to make copies of drugs that are deemed to be in shortage by the FDA, which semaglutide has been for over two years. But Novo argued that semaglutide ...
These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
Oct. 28, 2024 –The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.
The American Clinical Laboratory Association and the Association for Molecular Pathology sued the FDA, claiming regulatory overreach, in a case that has been consolidated in the U.S. District ...